Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Immunosuppressive Agents"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 48741
Tytuł:
Immunosuppressants exert antiviral effects against influenza A(H1N1)pdm09 virus via inhibition of nucleic acid synthesis, mRNA splicing, and protein stability.
Autorzy:
Wang X; Key Laboratory of Biotechnology and Bioengineering of State Ethnic Affairs Commission, Biomedical Research Center, Northwest Minzu University, Lanzhou, China.; School of Stomatology, Lanzhou University, Lanzhou, China.
Pu F; Key Laboratory of Biotechnology and Bioengineering of State Ethnic Affairs Commission, Biomedical Research Center, Northwest Minzu University, Lanzhou, China.
Yang X; Key Laboratory of Biotechnology and Bioengineering of State Ethnic Affairs Commission, Biomedical Research Center, Northwest Minzu University, Lanzhou, China.
Feng X; Key Laboratory of Biotechnology and Bioengineering of State Ethnic Affairs Commission, Biomedical Research Center, Northwest Minzu University, Lanzhou, China.
Zhang J; National Engineering Technology Research Center for Combined Vaccines, Wuhan, China.; Wuhan Institute of Biological Products Co, Ltd, Wuhan, China.
Duan K; National Engineering Technology Research Center for Combined Vaccines, Wuhan, China.; Wuhan Institute of Biological Products Co, Ltd, Wuhan, China.
Nian X; National Engineering Technology Research Center for Combined Vaccines, Wuhan, China.; Wuhan Institute of Biological Products Co, Ltd, Wuhan, China.
Ma Z; Key Laboratory of Biotechnology and Bioengineering of State Ethnic Affairs Commission, Biomedical Research Center, Northwest Minzu University, Lanzhou, China.
Ma XX; Key Laboratory of Biotechnology and Bioengineering of State Ethnic Affairs Commission, Biomedical Research Center, Northwest Minzu University, Lanzhou, China.
Yang XM; National Engineering Technology Research Center for Combined Vaccines, Wuhan, China.; China National Biotech Group Company Limited, Beijing, China.
Pokaż więcej
Źródło:
Virulence [Virulence] 2024 Dec; Vol. 15 (1), pp. 2301242. Date of Electronic Publication: 2024 Feb 06.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/drug therapy
Influenza A Virus, H1N1 Subtype*
Influenza A virus*/physiology
Orthomyxoviridae Infections*
Humans ; Oseltamivir/pharmacology ; Antiviral Agents/pharmacology ; Immunosuppressive Agents/pharmacology ; Virus Replication ; RNA, Messenger ; Protein Stability
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Global tuberculosis disease and infection in systemic lupus erythematosus patients: A systematic review and meta-analysis.
Autorzy:
Darmawan G; Doctoral Study Program, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.; Department of Internal Medicine, Faculty of Medicine, Krida Wacana Christian University, Jakarta, Indonesia.
Liman LMS; Bethel Medical Center, Jakarta, Indonesia.
Wibowo SAK; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
Hamijoyo L; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.
Apriani L; Department of Public Health, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.
Atik N; Department of Biomedical Sciences, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.
Alisjahbana B; Division of Infectious and Tropical Disease, Department of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.; Research Center for Care and Control of Infectious Disease, Universitas Padjadjaran, Bandung, Indonesia.
Sahiratmadja E; Department of Biomedical Sciences, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.
Pokaż więcej
Źródło:
Lupus [Lupus] 2024 May; Vol. 33 (6), pp. 555-573. Date of Electronic Publication: 2024 Mar 15.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/drug therapy
Lupus Erythematosus, Systemic*/epidemiology
Tuberculosis*/complications
Humans ; Risk Factors ; Glucocorticoids/adverse effects ; Immunosuppressive Agents/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Initiation of belimumab with higher daily prednisolone is effective for rapid glucocorticoid reduction: A 96-week retrospective study.
Autorzy:
Yamane T; Department of Rheumatology, Kakogawa Central City Hospital, Kakogawa, Japan.
Hashiramoto A; Department of Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan.
Pokaż więcej
Źródło:
Lupus [Lupus] 2024 May; Vol. 33 (6), pp. 598-607. Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:
Journal Article
MeSH Terms:
Lupus Erythematosus, Systemic*/drug therapy
Lupus Erythematosus, Systemic*/chemically induced
Lupus Nephritis*/chemically induced
Antibodies, Monoclonal, Humanized*
Humans ; Prednisolone/adverse effects ; Retrospective Studies ; Glucocorticoids/adverse effects ; Treatment Outcome ; Severity of Illness Index ; Immunosuppressive Agents/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The use of belimumab on patients with both systemic lupus erythematosus and immune thrombocytopenia: A retrospective cohort study.
Autorzy:
Wu Q; State Key Laboratory of Traditional Chinese Medicine Syndrome, Department of Rheumatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.; The First Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Zhao MX; State Key Laboratory of Traditional Chinese Medicine Syndrome, Department of Rheumatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.; The Third Hospital of Mianyang (Sichuan Mental Health Center), Mianyang, China.
Huang XS; State Key Laboratory of Traditional Chinese Medicine Syndrome, Department of Rheumatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.; The First Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Lin CS; State Key Laboratory of Traditional Chinese Medicine Syndrome, Department of Rheumatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.; The First Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Xu Q; State Key Laboratory of Traditional Chinese Medicine Syndrome, Department of Rheumatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.; The First Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Pokaż więcej
Źródło:
Lupus [Lupus] 2024 May; Vol. 33 (6), pp. 608-614. Date of Electronic Publication: 2024 Mar 22.
Typ publikacji:
Journal Article
MeSH Terms:
Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/drug therapy
Purpura, Thrombocytopenic, Idiopathic*/drug therapy
Thrombocytopenia*/drug therapy
Antibodies, Monoclonal, Humanized*
Humans ; Female ; Young Adult ; Adult ; Middle Aged ; Retrospective Studies ; Treatment Outcome ; Immunosuppressive Agents/adverse effects ; Severity of Illness Index
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The role of BAFF and BAFF-R inhibitors in the treatment of immune thrombocytopenia; a focused review.
Autorzy:
Nilforoushzadeh, Mohammad Ali (AUTHOR)
Heidari, Nazila (AUTHOR)
Heidari, Amirhossein (AUTHOR)
Ghane, Yekta (AUTHOR)
Lotfi, Zahra (AUTHOR)
Jaffary, Fariba (AUTHOR)
Najar Nobari, Minou (AUTHOR)
Najar Nobari, Niloufar (AUTHOR)
Pokaż więcej
Źródło:
International Immunopharmacology. Apr2024, Vol. 131, pN.PAG-N.PAG. 1p.
Czasopismo naukowe
Szczegóły
Tytuł:
Glucocorticoid-free remission in patients with SLE in the era of biologics: Immune complex disease is likely to benefit from current medications.
Autorzy:
Oiwa, Hiroshi
Suga, Takeshi
Hosokawa, Yohei
Araki, Kei
Pokaż więcej
Temat:
IMMUNE complexes
BIOLOGICALS
IMMUNOSUPPRESSIVE agents
DRUGS
DISEASE remission
ISCHEMIC colitis
Źródło:
Lupus; Apr2024, Vol. 33 Issue 5, p502-510, 9p
Terminy geograficzne:
JAPAN
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Novel T cell exhaustion gene signature to predict prognosis and immunotherapy response in thyroid carcinoma from integrated RNA-sequencing analysis.
Autorzy:
Li Y; Department of Endocrinology, First Affiliated Hospital of Anhui Medical University, Hefei, China.
Wang Z; Department of Endocrinology, First Affiliated Hospital of Anhui Medical University, Hefei, China.
Lu F; Department of Endocrinology, First Affiliated Hospital of Anhui Medical University, Hefei, China.
Miao Y; Department of Endocrinology, First Affiliated Hospital of Anhui Medical University, Hefei, China.
Feng Q; Department of Endocrinology, First Affiliated Hospital of Anhui Medical University, Hefei, China.
Zhu W; Department of Endocrinology, First Affiliated Hospital of Anhui Medical University, Hefei, China.
Kang Q; Department of Endocrinology, First Affiliated Hospital of Anhui Medical University, Hefei, China.
Chen Y; Department of Endocrinology, First Affiliated Hospital of Anhui Medical University, Hefei, China.
Zhang Q; Department of Endocrinology, First Affiliated Hospital of Anhui Medical University, Hefei, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Apr 10; Vol. 14 (1), pp. 8375. Date of Electronic Publication: 2024 Apr 10.
Typ publikacji:
Journal Article
MeSH Terms:
CD8-Positive T-Lymphocytes*
Thyroid Neoplasms*/genetics
Thyroid Neoplasms*/therapy
Humans ; T-Cell Exhaustion ; Prognosis ; Immunotherapy ; Immunosuppressive Agents ; RNA ; Tumor Microenvironment/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Adaptative Strategy of Immunosuppressive Drugs Dosage Adjustments When Combined With Nirmatrelvir/Ritonavir in Solid Organ Transplant Recipients With COVID-19.
Autorzy:
Boland, Lidvine
Devresse, Arnaud
Monchaud, Caroline
Briol, Sébastien
Belaiche, Stéphanie
Giguet, Baptiste
Couzi, Lionel
Thaunat, Olivier
Esposito, Laure
Meszaros, Magdalena
Roussoulieres, Ana
Haufroid, Vincent
Le Meur, Yannick
Lemaitre, Florian
Pokaż więcej
Źródło:
Transplant International. 2024, p1-9. 9p.
Czasopismo naukowe
Szczegóły
Tytuł:
Efficacy and safety of immunosuppressive therapy combined with eltrombopag for severe aplastic anemia: a systematic review and meta-analysis.
Autorzy:
Zhang Y; Department of Hematology, Heji Hospital Affiliated to Changzhi Medical College, Changzhi, 046000, Shanxi, China.
Li J; Department of Oncology and Hematology, Liuyang Hospital of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, 410300, Hunan, China.
Li X; Department of Nephrology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, 046000, Shanxi, China.
Geng Q; Department of Hematology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, 046000, Shanxi, China.
Xie Y; Department of Hematology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, 046000, Shanxi, China.
Zhang G; Department of Hematology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, 046000, Shanxi, China.
Wei M; Department of Hematology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, 046000, Shanxi, China. .
Ma Y; Department of Hematology, Heji Hospital Affiliated to Changzhi Medical College, Changzhi, 046000, Shanxi, China. .
Pokaż więcej
Źródło:
Systematic reviews [Syst Rev] 2024 Apr 04; Vol. 13 (1), pp. 101. Date of Electronic Publication: 2024 Apr 04.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Immunosuppressive Agents*/therapeutic use
Anemia, Aplastic*/drug therapy
Anemia, Aplastic*/epidemiology
Hydrazines*
Pyrazoles*
Humans ; Immunosuppression Therapy ; Benzoates/therapeutic use ; Pathologic Complete Response ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Immunogenicity and safety of BNT162b2 vaccination in adolescents with systemic lupus erythematosus.
Autorzy:
Piyaphanee N; Department of Paediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Charuvanij S; Department of Paediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Thepveera S; Department of Paediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Toh ZQ; Infection, Immunity and Global Health, Murdoch Children's Research Institute, Parkville, VIC, Australia.; Department of Paediatrics, The University of Melbourne, Parkville, VIC, Australia.
Licciardi PV; Infection, Immunity and Global Health, Murdoch Children's Research Institute, Parkville, VIC, Australia.; Department of Paediatrics, The University of Melbourne, Parkville, VIC, Australia.
Pattaragarn A; Department of Paediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Wongprompitak P; Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Boonnak K; Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Pheerapanyawaranun C; Siriraj Institute of Clinical Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Chokephaibulkit K; Department of Paediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.; Siriraj Institute of Clinical Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Pokaż więcej
Źródło:
Lupus [Lupus] 2024 Apr; Vol. 33 (5), pp. 450-461. Date of Electronic Publication: 2024 Feb 09.
Typ publikacji:
Journal Article
MeSH Terms:
Lupus Erythematosus, Systemic*/drug therapy
Humans ; Adolescent ; BNT162 Vaccine ; COVID-19 Vaccines/adverse effects ; Symptom Flare Up ; Prednisolone ; Immunosuppressive Agents/adverse effects ; Immunoglobulin G ; Antibodies, Viral ; Vaccination ; Immunogenicity, Vaccine
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Satisfaction and effectiveness of switching from intravenous to subcutaneous belimumab treatment in daily clinical practice.
Autorzy:
Frade-Sosa B; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Salman-Monte TC; Rheumatology Department, Hospital Del Mar/Parc de Salut Mar-IMIM, Barcelona, Spain.
Narváez J; Rheumatology Department, Hospital de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
Peralta I; Rheumatology Department, Hospital Universitario Germans Trias I Pujol, Badalona, Spain.
Sandoval S; Rheumatology Department, Hospital Vall D'Hebron, Barcelona, Spain.
Magallares B; Rheumatology Department, Hospital Santa Creu I Sant Pau, Barcelona, Spain.
Heredia S; Rheumatology Department, Hospital Moisès Broggi, Barcelona, Spain.
Sapena N; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Riveros-Frutos A; Rheumatology Department, Hospital Universitario Germans Trias I Pujol, Badalona, Spain.
Olivé A; Rheumatology Department, Hospital Universitario Germans Trias I Pujol, Badalona, Spain.
Corominas H; Rheumatology Department, Hospital Santa Creu I Sant Pau, Barcelona, Spain.
Cortés-Hernández J; Rheumatology Department, Hospital Vall D'Hebron, Barcelona, Spain.
Gómez-Puerta JA; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Faculty of Medicine, University of Barcelona, Barcelona, Spain.
Pokaż więcej
Źródło:
Lupus [Lupus] 2024 Apr; Vol. 33 (5), pp. 481-489. Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:
Observational Study; Multicenter Study; Journal Article
MeSH Terms:
Immunosuppressive Agents*/therapeutic use
Lupus Erythematosus, Systemic*/drug therapy
Antibodies, Monoclonal, Humanized*
Humans ; Treatment Outcome ; Personal Satisfaction
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Early add-on use of belimumab as induction therapy for patients with childhood-onset systemic lupus erythematosus.
Autorzy:
Hashimoto S; Department of Pediatrics, Hirosaki University Hospital, Hirosaki, Japan.
Fujita M; Department of Pediatrics, Hirosaki University Hospital, Hirosaki, Japan.
Aizawa T; Department of Pediatrics, Hirosaki University Hospital, Hirosaki, Japan.; Niji-iro Children's Clinic, Hirosaki, Japan.
Watanabe S; Department of Pediatrics, Hirosaki University Hospital, Hirosaki, Japan.; Department of Pediatrics, Ehime University Graduate School of Medicine, Toon City, Japan.
Tsugawa K; Department of Pediatrics, Hirosaki University Hospital, Hirosaki, Japan.
Tanaka H; Department of Pediatrics, Hirosaki University Hospital, Hirosaki, Japan.; Department of School Health Science, Hirosaki University Faculty of Education, Hirosaki, Japan.
Pokaż więcej
Źródło:
Lupus [Lupus] 2024 Apr; Vol. 33 (5), pp. 543-544. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:
Letter
MeSH Terms:
Lupus Erythematosus, Systemic*/drug therapy
Lupus Erythematosus, Systemic*/chemically induced
Humans ; Child ; Induction Chemotherapy ; Antibodies, Monoclonal, Humanized/therapeutic use ; Immunosuppressive Agents/therapeutic use ; Treatment Outcome
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparison of efficacy of continuous mycophenolate mofetil with sequential cyclophosphamide and tacrolimus as maintenance therapy for lupus nephritis.
Autorzy:
Kawazoe M; Division of Rheumatology, Department of Internal Medicine, School of Medicine, Faculty of Medicine, Toho University, Tokyo, Japan.
Nanki T; Division of Rheumatology, Department of Internal Medicine, School of Medicine, Faculty of Medicine, Toho University, Tokyo, Japan.
Pokaż więcej
Źródło:
Lupus [Lupus] 2024 Apr; Vol. 33 (4), pp. 319-327. Date of Electronic Publication: 2024 Jan 17.
Typ publikacji:
Journal Article
MeSH Terms:
Lupus Nephritis*/drug therapy
Lupus Nephritis*/chemically induced
Lupus Erythematosus, Systemic*/drug therapy
Humans ; Mycophenolic Acid ; Tacrolimus ; Immunosuppressive Agents/adverse effects ; Cyclophosphamide/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Refractory lupus hepatitis successfully treated with telitacicept who failed to belimumab: A case report and literature review.
Autorzy:
Fan Q; Department of Immunology, Wuhan No. 1 Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Ji H; Department of Dermatology, Wuhan No. 1 Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Liu Y; Department of Immunology, Wuhan No. 1 Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Jia C; Department of Immunology, Wuhan No. 1 Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zou L; Department of Immunology, Wuhan No. 1 Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yang H; Department of Immunology, Wuhan No. 1 Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Pokaż więcej
Źródło:
Lupus [Lupus] 2024 Apr; Vol. 33 (4), pp. 414-419. Date of Electronic Publication: 2024 Feb 06.
Typ publikacji:
Review; Case Reports; Journal Article
MeSH Terms:
Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/drug therapy
Hepatitis*/drug therapy
Recombinant Fusion Proteins*
Antibodies, Monoclonal, Humanized*
Humans ; Prospective Studies ; Treatment Outcome ; Immunosuppressive Agents/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Asymptomatic spinal lesions in patients with AQP4-IgG-positive NMOSD: A real-world cohort study.
Autorzy:
Cao S; Department of Neurology, Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.; Department of Neurology, The Second People's Hospital of Hefei, Hefei Hospital Affiliated to Anhui Medical University, Hefei, 230011, China.
Zhu Y; Department of Neurology, First Affiliated Hospital of Soochow University, Suzhou, 215006, China.
Wu X; Department of Neurology, Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
Du J; Department of Neurology, Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
Xu S; Department of Neurology, Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
Cui P; Department of Radiology, The Second People's Hospital of Hefei, Hefei Hospital Affiliated to Anhui Medical University, Hefei, 230011, China.
Li Q; Department of Neurology, Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
Xia M; Department of Neurology, The Second People's Hospital of Hefei, Hefei Hospital Affiliated to Anhui Medical University, Hefei, 230011, China.
Xue Q; Department of Neurology, First Affiliated Hospital of Soochow University, Suzhou, 215006, China.
Tian Y; Department of Neurology, Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
Pokaż więcej
Źródło:
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2024 Apr; Vol. 11 (4), pp. 905-915. Date of Electronic Publication: 2024 Feb 04.
Typ publikacji:
Journal Article
MeSH Terms:
Neuromyelitis Optica*/drug therapy
Humans ; Cohort Studies ; Aquaporin 4 ; Rituximab/therapeutic use ; Retrospective Studies ; Immunosuppressive Agents/therapeutic use ; Recurrence ; Immunoglobulin G
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Nicolau syndrome following glatiramer acetate for multiple sclerosis: Case and review of reports.
Autorzy:
Udawatta M; Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Mateen FJ; Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2024 Apr; Vol. 11 (4), pp. 1080-1085. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:
Case Reports
MeSH Terms:
Multiple Sclerosis*/drug therapy
Nicolau Syndrome*/etiology
Humans ; Glatiramer Acetate/adverse effects ; Immunosuppressive Agents/adverse effects
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 48741

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies